21 employees
InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
1981
$12M
from 1 investors over 1 rounds
InMed Pharmaceuticals raised $12M on June 12, 2018
Investors: Eight Capital Management